Barclays’s Arcosa ACA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.62M | Sell |
15,223
-91,692
| -86% | -$10.4M | ﹤0.01% | 2491 |
|
|
2025
Q4 | $11.4M | Buy |
106,915
+12,630
| +13% | +$1.27M | ﹤0.01% | 1594 |
|
|
2025
Q3 | $8.84M | Sell |
94,285
-3,917
| -4% | -$364K | ﹤0.01% | 1757 |
|
|
2025
Q2 | $8.52M | Buy |
98,202
+35,379
| +56% | +$2.96M | ﹤0.01% | 1690 |
|
|
2025
Q1 | $4.84M | Sell |
62,823
-23,106
| -27% | -$2.12M | ﹤0.01% | 1946 |
|
|
2024
Q4 | $8.31M | Buy |
85,929
+4,147
| +5% | +$417K | ﹤0.01% | 1713 |
|
|
2024
Q3 | $7.75M | Buy |
81,782
+62,804
| +331% | +$5.48M | ﹤0.01% | 1680 |
|
|
2024
Q2 | $1.58M | Sell |
18,978
-24,795
| -57% | -$2.07M | ﹤0.01% | 2303 |
|
|
2024
Q1 | $3.76M | Sell |
43,773
-32,555
| -43% | -$2.65M | ﹤0.01% | 2053 |
|
|
2023
Q4 | $6.31M | Buy |
76,328
+52,196
| +216% | +$3.83M | ﹤0.01% | 1903 |
|
|
2023
Q3 | $1.74M | Sell |
24,132
-2,109
| -8% | -$160K | ﹤0.01% | 1983 |
|
|
2023
Q2 | $1.99M | Buy |
26,241
+616
| +2% | +$41.4K | ﹤0.01% | 1891 |
|
|
2023
Q1 | $1.62M | Buy |
25,625
+2,214
| +9% | +$130K | ﹤0.01% | 2345 |
|
|
2022
Q4 | $1.27M | Buy |
23,411
+3,034
| +15% | +$180K | ﹤0.01% | 2612 |
|
|
2022
Q3 | $1.16M | Sell |
20,377
-605
| -3% | -$33.5K | ﹤0.01% | 2124 |
|
|
2022
Q2 | $974K | Sell |
20,982
-18,981
| -47% | -$995K | ﹤0.01% | 2379 |
|
|
2022
Q1 | $2.29M | Sell |
39,963
-24,602
| -38% | -$1.27M | ﹤0.01% | 1766 |
|
|
2021
Q4 | $3.4M | Buy |
64,565
+25,691
| +66% | +$1.37M | ﹤0.01% | 1990 |
|
|
2021
Q3 | $1.95M | Buy |
38,874
+11,114
| +40% | +$576K | ﹤0.01% | 2382 |
|
|
2021
Q2 | $1.63M | Sell |
27,760
-48,703
| -64% | -$3.01M | ﹤0.01% | 2332 |
|
|
2021
Q1 | $4.98M | Buy |
76,463
+14,380
| +23% | +$883K | ﹤0.01% | 1519 |
|
|
2020
Q4 | $3.41M | Sell |
62,083
-5,239
| -8% | -$267K | ﹤0.01% | 1811 |
|
|
2020
Q3 | $2.97M | Buy |
67,322
+8,201
| +14% | +$360K | ﹤0.01% | 1778 |
|
|
2020
Q2 | $2.5M | Buy |
59,121
+3,439
| +6% | +$132K | ﹤0.01% | 1904 |
|
|
2020
Q1 | $2.21M | Sell |
55,682
-25,149
| -31% | -$1.06M | ﹤0.01% | 2193 |
|
|
2019
Q4 | $3.6M | Buy |
80,831
+4,056
| +5% | +$156K | ﹤0.01% | 2369 |
|
|
2019
Q3 | $2.63M | Sell |
76,775
-6,836
| -8% | -$237K | ﹤0.01% | 2527 |
|
|
2019
Q2 | $3.15M | Buy |
83,611
+1,197
| +1% | +$40.9K | ﹤0.01% | 2377 |
|
|
2019
Q1 | $2.52M | Buy |
82,414
+39,179
| +91% | +$1.2M | ﹤0.01% | 2326 |
|
|
2018
Q4 | $1.2M | Buy |
+43,235
| New | +$1.19M | ﹤0.01% | 2931 |
|
Other funds holding ACA
VPM
VCM
RA
Barclays's ACA Position: Q1 2026 in Review
Barclays reduced its Arcosa (ACA) stake by 86% in Q1 2026, selling an estimated $10.4M and leaving 15,223 shares worth $1.62M. The position accounts for ﹤0.01% of the portfolio, ranked #2491.
Barclays first reported a position in ACA in Q4 2018 and has held it in 30 quarters since. The position peaked at $11.4M in Q4 2025. 372 funds tracked by Wall St. Rank hold ACA as of Q1 2026.
- Barclays held 15,223 shares of Arcosa worth $1.62M as of Q1 2026.
- Barclays sold 91,692 Arcosa shares in Q1 2026, an estimated $10.4M.
- Arcosa made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #2491 holding.
- Barclays first reported a position in Arcosa in Q4 2018 and has held it in 30 quarters since.
- Barclays's Arcosa position peaked at $11.4M in Q4 2025.
- 372 funds tracked by Wall St. Rank held Arcosa as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.